Long-term complications of permanent hypoparathyroidism in adults: prevalence and associated factors
- 9 March 2024
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 84 (3) , 1164-1171
Abstract
Introduction Patients with Chronic hypoparathyroidism (CHPT) receiving conventional treatment are exposed to several long-term complications including basal ganglia calcifications, posterior subcapsular cataract, kidney stones, and renal insufficiency. The aim of this study was to assess the prevalence and the associated factors of these complications in patients with CHPT. Methods We conducted a cross-sectional study including 58 patients with CHPT. All participants underwent physical examination, biochemical assessment (total serum calcium, serum phosphorus, serum albumin, intact-PTH, serum magnesium, 25-hydroxy-vitamin D, serum creatinine, thyroid stimulating hormone (TSH), and 24-hour urinary calcium), slit lamp examination, brain computed tomography scan (CT-scan), and renal ultrasound. Results Participants had a mean age of 52.6 ± 16.4 years and a gender ratio (women/men) of 3.5. Fahr syndrome, cataract, urolithiasis, and renal failure were found in 55%, 62%, 12%, and 17% of cases, respectively. CHPT duration >15 years (Adjusted-OR = 43.1, 95-CI: 2.63–703.06, p = 0.008) and poor adherence to treatment (Adjusted-OR = 8.04, 95%-CI: 1.52–42.42, p = 0.014) were independently associated with the risk of Fahr syndrome. Age >55 years (adjusted-OR = 5.07, 95-CI: 1.10–23.42, p = 0.037), disease duration >15 years (adjusted-OR = 20.21, 95-CI: 1.54–265.84, p = 0.022), and magnesium level p = 0.002) were independently associated with the risk of subcapsular cataract. Only hypercalciuria (Adjusted-OR = 21.27, 95-CI: 2.31–195.91, p = 0.007) was an independent risk factor for kidney stones. Renal failure was not associated with kidney stones (p = 1). However, creatinine clearance was negatively correlated with age (r = −0.784; p < 10−3) and disease duration (r = −0.352; p = 0.007). Conclusion Our results revealed high prevalences of neurological, ocular, and renal complications in patients with CHPT and emphasized the importance of regular biological monitoring, therapeutic adjustments, screening, and adherence to treatment in the prevention of these complications.Keywords
This publication has 39 references indexed in Scilit:
- European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adultsEuropean Journal of Endocrinology, 2015
- Long-Term Follow-Up of Patients with HypoparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2012
- Magnesium deficiency: Does it have a role to play in cataractogenesis?Experimental Eye Research, 2012
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- [Renal function estimation by MDRD equation: interest and limitations for drug dosing].2008
- Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin DEuropean Journal of Endocrinology, 2002
- [Fahr syndrome and dysparathyroidism. 3 cases].1995
- [Ca(2+)-ATPase activity in the hypocalcemic cataract].1994
- Prevalences of CT-detected calcification in the basal ganglia in idiophathic hypoparathyroidism and pseudohypoparathyroidismNeuroradiology, 1985
- Basal ganglia calcifications on CTNeurology, 1982